← Back to headlines
Gilead's Hepcludex Wins FDA Approval for Chronic HDV Infection
Gilead Sciences' drug Hepcludex has received FDA approval for the treatment of chronic Hepatitis Delta Virus (HDV) infection, marking a significant development in health.
22 May, 18:07 — 22 May, 18:07
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
28m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
3h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
6h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
14h ago